101.36
3.32 (3.39%)
| Penutupan Terdahulu | 98.04 |
| Buka | 98.85 |
| Jumlah Dagangan | 8,827,545 |
| Purata Dagangan (3B) | 9,497,438 |
| Modal Pasaran | 150,260,318,208 |
| Harga / Pendapatan (P/E TTM) | 52.25 |
| Harga / Pendapatan (P/E Ke hadapan) | 29.15 |
| Harga / Jualan (P/S) | 7.79 |
| Harga / Buku (P/B) | 6.40 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 22 Oct 2025 |
| Margin Keuntungan | 11.58% |
| Margin Operasi (TTM) | 20.09% |
| EPS Cair (TTM) | 1.37 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 20.90% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 36.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 52.16% |
| Nisbah Semasa (MRQ) | 1.45 |
| Aliran Tunai Operasi (OCF TTM) | 3.81 B |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 2.32 B |
| Pulangan Atas Aset (ROA TTM) | 5.28% |
| Pulangan Atas Ekuiti (ROE TTM) | 9.50% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Boston Scientific Corporation | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -2.0 |
| Purata | 0.63 |
|
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Large Core |
| % Dimiliki oleh Orang Dalam | 0.18% |
| % Dimiliki oleh Institusi | 93.22% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Bollard Group Llc | 30 Sep 2025 | 19,733,573 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 140.00 (UBS, 38.12%) | Beli |
| Median | 128.00 (26.28%) | |
| Rendah | 110.00 (Evercore ISI Group, 8.52%) | Beli |
| Purata | 127.85 (26.14%) | |
| Jumlah | 13 Beli | |
| Harga Purata @ Panggilan | 99.77 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| BTIG | 21 Nov 2025 | 132.00 (30.23%) | Beli | 96.88 |
| 22 Oct 2025 | 132.00 (30.23%) | Beli | 103.85 | |
| Canaccord Genuity | 23 Oct 2025 | 132.00 (30.23%) | Beli | 102.39 |
| 01 Oct 2025 | 132.00 (30.23%) | Beli | 95.85 | |
| Morgan Stanley | 23 Oct 2025 | 130.00 (28.26%) | Beli | 102.39 |
| Truist Securities | 23 Oct 2025 | 130.00 (28.26%) | Beli | 102.39 |
| 01 Oct 2025 | 129.00 (27.27%) | Beli | 95.85 | |
| UBS | 23 Oct 2025 | 140.00 (38.12%) | Beli | 102.39 |
| Wells Fargo | 23 Oct 2025 | 125.00 (23.32%) | Beli | 102.39 |
| Needham | 17 Oct 2025 | 121.00 (19.38%) | Beli | 99.24 |
| 01 Oct 2025 | 121.00 (19.38%) | Beli | 95.85 | |
| Evercore ISI Group | 07 Oct 2025 | 110.00 (8.52%) | Beli | 95.90 |
| Barclays | 02 Oct 2025 | 136.00 (34.18%) | Beli | 96.22 |
| Baird | 01 Oct 2025 | 128.00 (26.28%) | Beli | 95.85 |
| Leerink Partners | 01 Oct 2025 | 128.00 (26.28%) | Beli | 95.85 |
| RBC Capital | 29 Sep 2025 | 125.00 (23.32%) | Beli | 97.04 |
| Oppenheimer | 08 Sep 2025 | 125.00 (23.32%) | Beli | 108.14 |
| Papar semua | ||||
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 03 Nov 2025 | Pengumuman | Boston Scientific announces upcoming investor conference schedule |
| 22 Oct 2025 | Pengumuman | Boston Scientific announces results for third quarter 2025 |
| 17 Oct 2025 | Pengumuman | Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc. |
| 01 Oct 2025 | Pengumuman | Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million |
| 09 Sep 2025 | Pengumuman | Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |